Precision BioSciences Inc (DTIL)
10.52
-0.32
(-2.95%)
USD |
NASDAQ |
May 03, 16:00
10.38
-0.14
(-1.38%)
After-Hours: 20:00
Precision BioSciences Cash from Financing (Quarterly): 2.828M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.828M |
| September 30, 2023 | -0.034M |
| June 30, 2023 | 1.852M |
| March 31, 2023 | 0.741M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -0.18M |
| June 30, 2022 | 92.92M |
| March 31, 2022 | 2.249M |
| December 31, 2021 | 8.378M |
| September 30, 2021 | 11.92M |
| June 30, 2021 | 13.51M |
| March 31, 2021 | 36.72M |
| Date | Value |
|---|---|
| December 31, 2020 | 0.198M |
| September 30, 2020 | 0.532M |
| June 30, 2020 | 0.285M |
| March 31, 2020 | 0.314M |
| December 31, 2019 | 0.706M |
| September 30, 2019 | 0.061M |
| June 30, 2019 | 134.31M |
| March 31, 2019 | 38.30M |
| December 31, 2018 | -1.592M |
| September 30, 2018 | 21.32M |
| June 30, 2018 | 88.03M |
| March 31, 2018 | 0.02M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.18M
Minimum
Sep 2022
134.31M
Maximum
Jun 2019
16.17M
Average
0.741M
Median
Mar 2023
Cash from Financing (Quarterly) Benchmarks
| Altimmune Inc | 72.75M |
| BioVie Inc | 4.922M |
| Adial Pharmaceuticals Inc | 3.384M |
| Gritstone Bio Inc | 15.72M |
| Humacyte Inc | -0.335M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.423M |
| Cash from Investing (Quarterly) | 0.042M |
| Free Cash Flow | -86.39M |
| Free Cash Flow Per Share (Quarterly) | -2.022 |
| Free Cash Flow to Equity (Quarterly) | -8.465M |
| Free Cash Flow Yield | -211.7% |